218 related articles for article (PubMed ID: 8205548)
1. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma.
Dole M; Nuñez G; Merchant AK; Maybaum J; Rode CK; Bloch CA; Castle VP
Cancer Res; 1994 Jun; 54(12):3253-9. PubMed ID: 8205548
[TBL] [Abstract][Full Text] [Related]
2. Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis.
Dole MG; Jasty R; Cooper MJ; Thompson CB; Nuñez G; Castle VP
Cancer Res; 1995 Jun; 55(12):2576-82. PubMed ID: 7780971
[TBL] [Abstract][Full Text] [Related]
3. Bcl-xL is expressed in ovarian carcinoma and modulates chemotherapy-induced apoptosis.
Liu JR; Fletcher B; Page C; Hu C; Nunez G; Baker V
Gynecol Oncol; 1998 Sep; 70(3):398-403. PubMed ID: 9790794
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer.
Miyake H; Hanada N; Nakamura H; Kagawa S; Fujiwara T; Hara I; Eto H; Gohji K; Arakawa S; Kamidono S; Saya H
Oncogene; 1998 Feb; 16(7):933-43. PubMed ID: 9484785
[TBL] [Abstract][Full Text] [Related]
5. Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival.
Lock RB; Stribinskiene L
Cancer Res; 1996 Sep; 56(17):4006-12. PubMed ID: 8752171
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
Henkels KM; Turchi JJ
Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
[TBL] [Abstract][Full Text] [Related]
7. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
Sawada M; Nakashima S; Banno Y; Yamakawa H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Nozawa Y
Oncogene; 2000 Jul; 19(31):3508-20. PubMed ID: 10918609
[TBL] [Abstract][Full Text] [Related]
8. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression.
Kern MA; Helmbach H; Artuc M; Karmann D; Jurgovsky K; Schadendorf D
Anticancer Res; 1997; 17(6D):4359-70. PubMed ID: 9494534
[TBL] [Abstract][Full Text] [Related]
9. Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis.
Walton MI; Whysong D; O'Connor PM; Hockenbery D; Korsmeyer SJ; Kohn KW
Cancer Res; 1993 Apr; 53(8):1853-61. PubMed ID: 8467505
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.
Blood A; Edwards CJ; Ishii HH; Pat BK; Bryson G; Sculley TB; Gobe GC
Arch Virol; 2004 Feb; 149(2):289-302. PubMed ID: 14745596
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2 expression inhibits prostaglandin E2-mediated apoptosis in B cell lymphomas.
Brown DM; Phipps RP
J Immunol; 1996 Aug; 157(4):1359-70. PubMed ID: 8759715
[TBL] [Abstract][Full Text] [Related]
12. Bcl-xS enhances adenoviral vector-induced apoptosis in neuroblastoma cells.
Dole MG; Clarke MF; Holman P; Benedict M; Lu J; Jasty R; Eipers P; Thompson CB; Rode C; Bloch C; Nuñez ; Castle VP
Cancer Res; 1996 Dec; 56(24):5734-40. PubMed ID: 8971184
[TBL] [Abstract][Full Text] [Related]
13. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
14. Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells.
Cinatl J; Cinatl J; Vogel JU; Kotchetkov R; Driever PH; Kabickova H; Kornhuber B; Schwabe D; Doerr HW
Cancer Res; 1998 Jan; 58(2):367-72. PubMed ID: 9443419
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of etoposide (VP-16)-induced DNA recombination and mutant frequency by Bcl-2 protein overexpression.
Hashimoto H; Chatterjee S; Berger NA
Cancer Res; 1995 Sep; 55(18):4029-35. PubMed ID: 7664276
[TBL] [Abstract][Full Text] [Related]
16. Resistance to chemotherapy mediated by TrkB in neuroblastomas.
Ho R; Eggert A; Hishiki T; Minturn JE; Ikegaki N; Foster P; Camoratto AM; Evans AE; Brodeur GM
Cancer Res; 2002 Nov; 62(22):6462-6. PubMed ID: 12438236
[TBL] [Abstract][Full Text] [Related]
17. bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways.
Fisher TC; Milner AE; Gregory CD; Jackman AL; Aherne GW; Hartley JA; Dive C; Hickman JA
Cancer Res; 1993 Jul; 53(14):3321-6. PubMed ID: 8324744
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.
Hanada M; Krajewski S; Tanaka S; Cazals-Hatem D; Spengler BA; Ross RA; Biedler JL; Reed JC
Cancer Res; 1993 Oct; 53(20):4978-86. PubMed ID: 8402688
[TBL] [Abstract][Full Text] [Related]
19. bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair.
Kamesaki S; Kamesaki H; Jorgensen TJ; Tanizawa A; Pommier Y; Cossman J
Cancer Res; 1993 Sep; 53(18):4251-6. PubMed ID: 8395979
[TBL] [Abstract][Full Text] [Related]
20. Differential oncogene expression and susceptibility to apoptosis in the human leukemia HL60 cell lines: implications for etoposide resistance.
Eliot HE; Borner MM; Sinha BK
Anticancer Res; 1995; 15(3):729-33. PubMed ID: 7645949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
